Scott Hutton insider trades

Open-market stock purchases and sales by Scott Hutton, President & CEO at Biodesix Inc, from SEC Form 4 filings since Jan 31, 2017.

Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +63%.

Recent trades

DateStockTradeValue
Feb 23, 2026BDSX Biodesix IncSold$19K
Feb 20, 2026BDSX Biodesix IncBought (not open market)—
Feb 10, 2026BDSX Biodesix IncSold$35.9K
Feb 9, 2026BDSX Biodesix IncBought (not open market)—
Feb 9, 2026BDSX Biodesix IncBought (not open market)—
Feb 9, 2026BDSX Biodesix IncBought (not open market)—
Jan 16, 2026BDSX Biodesix IncSold$7.9K
Jan 15, 2026BDSX Biodesix IncBought (not open market)—
Jan 2, 2026BDSX Biodesix IncBought (not open market)—
Nov 10, 2025BDSX Biodesix IncBought (not open market)—
Nov 10, 2025BDSX Biodesix IncSold$1.4K

Companies traded

  • BDSX Biodesix Inc: 2 buys, 26 sales, last Feb 23, 2026
  • SPNC Spectranetics Corp: other filings, last Aug 9, 2017

Get free alerts when Scott Hutton files a new trade →